News

Home>News>

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

STAT Biotech – By Sharon Begley @sxbegle

JUNE 25, 2019

The U.S. patent office has declared an interference between a dozen key patents awarded to the Broad Institute on the genome-editing technology CRISPR and 10 CRISPR patent applications submitted by the University of California and its partners, according to documents posted by the U.S. Patent and […]

2019-07-03T01:17:02+10:00July 3rd, 2019|

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating their support for rapid progress towards clinical trials for major cancers. The Nguyen’s are Australian pharmaceutical providers and are strong supporters of Cartherics.
Pictured from left to right: Thao Nguyen, Alan Trounson, Bob Moses and Luyen Nguyen.
2019-06-24T01:35:25+10:00June 24th, 2019|

Science and Technology priorities – Election 2019

MEDIA RELEASE

8 May 2019 Parties use science to set themselves apart ….

The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.

Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]

2019-05-08T04:07:34+10:00May 8th, 2019|

Miracle Elixirs

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a yearning that can cloud our judgment.

The Scientist

Apr 1, 2019

BOB GRANT Editor-in-Chief

Cancer has bedeviled humankind since long before scientists even had a word to describe the dread disease. It is therefore understandable that our ears […]

2019-04-04T03:27:36+11:00April 4th, 2019|

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

April 01, 2019  |  Yadira Galindo

After 10 years in remission, Derek Ruff’s cancer returned, this […]

2019-04-02T02:22:48+11:00April 2nd, 2019|

Tom’s Long Fight

Tom Long’s battle with Multiple Myeloma

Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia.  The story is heartbreaking, Tom is hanging on to hope.  Hope that a CAR-T cell treatment that he has to […]

2019-03-25T23:18:28+11:00March 25th, 2019|
Go to Top